The Application of Plant-exosome-like Nanovesicles As Improved Drug Delivery Systems for Cancer Vaccines

Overview

Journal Discov Oncol

Publisher Springer

Specialty Oncology

Date 2024 Apr 29

PMID 38683256

Authors

Tatiana Hillman

Affiliations

Soon will be listed here.

Abstract

The use of cancer immunotherapeutics is currently increasing. Cancer vaccines, as a form of immunotherapy, are gaining much attention in the medical community since specific tumor-antigens can activate immune cells to induce an anti-tumor immune response. However, the delivery of cancer vaccines presents many issues for research scientists when designing cancer treatments and requires further investigation. Nanoparticles, synthetic liposomes, bacterial vectors, viral particles, and mammalian exosomes have delivered cancer vaccines. In contrast, the use of many of these nanotechnologies produces many issues of cytotoxicity, immunogenicity, and rapid clearance by the mononuclear phagocyte system (MPS). Plant-exosome-like nanovesicles (PELNVs) can provide solutions for many of these challenges because they are innocuous and nonimmunogenic when delivering nanomedicines. Hence, this review will describe the potential use of PELNVs to deliver cancer vaccines. In this review, different approaches of cancer vaccine delivery will be detailed, the mechanism of oral vaccination for delivering cancer vaccines will be described, and the review will discuss the use of PELNVs as improved drug delivery systems for cancer vaccines via oral administration while also addressing the subsequent challenges for advancing their usage into the clinical setting.

Citing Articles

Utilization of Cannabidiol in Post-Organ-Transplant Care.

Koyama S, Etkins J, Jun J, Miller M, So G, Gisch D Int J Mol Sci. 2025; 26(2).

PMID: 39859413 PMC: 11765766. DOI: 10.3390/ijms26020699.

References

Wang X, Devaiah S, Zhang W, Welti R . Signaling functions of phosphatidic acid. Prog Lipid Res. 2006; 45(3):250-78. DOI: 10.1016/j.plipres.2006.01.005. View

Yang C, Zhang M, Merlin D . Advances in Plant-derived Edible Nanoparticle-based lipid Nano-drug Delivery Systems as Therapeutic Nanomedicines. J Mater Chem B. 2018; 6(9):1312-1321. PMC: 6053076. DOI: 10.1039/C7TB03207B. View

Marie-Cardine A, Viaud N, Thonnart N, Joly R, Chanteux S, Gauthier L . IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma. Cancer Res. 2014; 74(21):6060-70. DOI: 10.1158/0008-5472.CAN-14-1456. View

Rezaie J, Feghhi M, Etemadi T . A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal. 2022; 20(1):145. PMC: 9483361. DOI: 10.1186/s12964-022-00959-4. View

Cong M, Tan S, Li S, Gao L, Huang L, Zhang H . Technology insight: Plant-derived vesicles-How far from the clinical biotherapeutics and therapeutic drug carriers?. Adv Drug Deliv Rev. 2022; 182:114108. DOI: 10.1016/j.addr.2021.114108. View

Afrin H, Bai R, Kumar R, Ahmad S, Agarwal S, Nurunnabi M . Oral delivery of RNAi for cancer therapy. Cancer Metastasis Rev. 2023; 42(3):699-724. PMC: 10040933. DOI: 10.1007/s10555-023-10099-x. View

Rupert D, Claudio V, Lasser C, Bally M . Methods for the physical characterization and quantification of extracellular vesicles in biological samples. Biochim Biophys Acta Gen Subj. 2016; 1861(1 Pt A):3164-3179. DOI: 10.1016/j.bbagen.2016.07.028. View

Xing H, Tan J, Miao Y, Lv Y, Zhang Q . Crosstalk between exosomes and autophagy: A review of molecular mechanisms and therapies. J Cell Mol Med. 2021; 25(5):2297-2308. PMC: 7933923. DOI: 10.1111/jcmm.16276. View

Rudin A, Riise G, Holmgren J . Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun. 1999; 67(6):2884-90. PMC: 96596. DOI: 10.1128/IAI.67.6.2884-2890.1999. View

10.

Pulendran B, Arunachalam P, OHagan D . Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021; 20(6):454-475. PMC: 8023785. DOI: 10.1038/s41573-021-00163-y. View

11.

Lamichhane T, Raiker R, Jay S . Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery. Mol Pharm. 2015; 12(10):3650-7. PMC: 4826735. DOI: 10.1021/acs.molpharmaceut.5b00364. View

12.

Choi H, Kim M, Kim D, Yun H, Oh B, Kim S . Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with Zr Radioisotope in Mice and Rats. Pharmaceutics. 2022; 14(6). PMC: 9229812. DOI: 10.3390/pharmaceutics14061118. View

13.

Smyth T, Petrova K, Payton N, Persaud I, Redzic J, Graner M . Surface functionalization of exosomes using click chemistry. Bioconjug Chem. 2014; 25(10):1777-84. PMC: 4198107. DOI: 10.1021/bc500291r. View

14.

Del Giudice G, Rappuoli R, Didierlaurent A . Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. Semin Immunol. 2018; 39:14-21. DOI: 10.1016/j.smim.2018.05.001. View

15.

Atalis A, Keenum M, Pandey B, Beach A, Pradhan P, Vantucci C . Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine. J Control Release. 2022; 347:476-488. PMC: 9121740. DOI: 10.1016/j.jconrel.2022.05.023. View

16.

Wang Q, Ren Y, Mu J, Egilmez N, Zhuang X, Deng Z . Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites. Cancer Res. 2015; 75(12):2520-9. PMC: 4470740. DOI: 10.1158/0008-5472.CAN-14-3095. View

17.

Hassanpour M, Rezaie J, Darabi M, Hiradfar A, Rahbarghazi R, Nouri M . Autophagy modulation altered differentiation capacity of CD146 cells toward endothelial cells, pericytes, and cardiomyocytes. Stem Cell Res Ther. 2020; 11(1):139. PMC: 7099797. DOI: 10.1186/s13287-020-01656-0. View

18.

Mulcahy L, Pink R, Carter D . Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014; 3. PMC: 4122821. DOI: 10.3402/jev.v3.24641. View

19.

Marasini N, Skwarczynski M, Toth I . Oral delivery of nanoparticle-based vaccines. Expert Rev Vaccines. 2014; 13(11):1361-76. DOI: 10.1586/14760584.2014.936852. View

20.

Park J, Choi J, Kim K, Byun Y . Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex. Biomaterials. 2017; 147:145-154. DOI: 10.1016/j.biomaterials.2017.09.022. View